← SynDRA
AC-480
SynDRA canonical compound SYN0026058 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | ERBB4 |
|---|
| Mechanism of action | Receptor tyrosine protein kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- EGFR INHIBITOR
- Receptor tyrosine protein kinase inhibitor
- Epidermal growth factor receptor erbB1 inhibitor
- ERBB2 INHIBITOR
- Receptor protein-tyrosine kinase erbB-2 inhibitor
- ERBB4 INHIBITOR
- Receptor protein-tyrosine kinase erbB-4 inhibitor
- tyrosine kinase inhibitor
Cross-references
Synonyms
- BMS-599626
- AC480
- BMS 599626
- AC 480
- (S)-Morpholin-3-ylmethyl (4-((1-(3-fluorobenzyl)-1H-indazol-5-yl)amino)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)carbamate
- UNII-2252724U5N
- CHEMBL1645462
- BMS599626
- AC480 (BMS-599626)
- 2252724U5N
- J-502499
- C27H27FN8O3
- AC1480 (free base)
- PubChem22432
- GTPL7647
- SCHEMBL12065349
- CTK8B6780
- DTXSID60221714
- SYN1142
- AOB5594
- MolPort-023-279-418
- EX-A2296
- ZINC6717782
- KS-000008GE
- BDBM50333373
- s1056
- C27H44O11
- ANW-54337
- AKOS015999853
- CS-0407
- RL05125
- BCP9000428
- SB21703
- Bms-599626
- RefChem:120731
- DTXCID90144205
- PAN-HER KINASE INHIBITOR AC480
- MFCD10565678
Look up AC-480 in the interactive SynDRA portal →